AKT1 and cervical carcinoma: These findings indicate that the natural compound Zey may be a novel therapeutic approach to selectively target the PI3K/AKT/mTOR and MAPK/ERK pathways in cervical carcinoma cells, providing a therapeutic option in the treatment of cervical carcinoma.